Browse 133 market data tables, 52 figures spread through 265 pages and in-depth TOC on “Molecular Biology, Kits, Enzymes & Reagents Market”
http://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html
Early buyers will receive 10% customization on reports.

The global molecular biology enzymes, kits & reagents market was valued at $2,847.63 million in 2013. This market is expected to grow at a CAGR of 13.74% to reach $5,420.63 million in 2018.

The market is segmented on the basis of applications, end users and products. By application, the market is divided into cloning, epigenetics, PCR (Polymerase Chain Reaction), restriction digestion, sequencing, and other applications. Of these, the PCR applications segment accounted for the largest share of the molecular biology kits, enzymes and reagents market in 2013. The end-user segments included in this report are academic research institutes, hospital and diagnostic centers, pharmaceutical and biotech companies, and other end users. By products, the market is segmented into enzymes, and kits and reagents.

Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=164131709

The enzymes product segment consists of seven sub-segments, namely, ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptase, and other enzymes. Of these, the polymerase enzyme product sub-segment had the largest share of the molecular biology enzymes market in 2013, and is poised to grow at the highest CAGR between 2013 and 2018. The kits and reagents segment is divided into cloning and mutagenesis, nucleic acid analysis, PCR, sequencing, and other kits and reagents.

The geographic segments included in this report are Asia, Europe, North America, and Rest of the World. The Asian segment is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and Rest of Europe. North America includes Canada, and the U.S. The Rest of the World geographic segment encompasses Latin America, Middle East and Africa, and the Pacific region.

Speak to Research Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=164131709

Increases in R&D expenditure by pharmaceutical and biotech companies and investments in life science and genomics research will be the two most important growth drivers for this market in the forecast period (2013–2018). For instance, the Chinese government increased its basic research investment by 26% from 2011 to 2012 and put more than $300 billion into biotechnology from 2012 to 2017. Similarly, in 2011, Europe increased investment in research to $108 billion in 2014-2020. This will increase the demand for products offered by the molecular biology kits, enzymes and reagents market. Moreover, the increase in the aged population, at risk of contracting chronic and infectious diseases, will further boost the need for research into ailments such as cancer and heart diseases, further increasing the demand for molecular biology kits, enzymes and reagents products.

The major players in the molecular biology kits, enzymes and reagents market include Affymetrix, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Enzymatics, Inc. (U.S.), Illumina, Inc. (U.S.), New England Biolabs, Inc. (U.S.), QIAGEN, N.V. (Netherlands), Roche, Ltd. (Switzerland), Sigma-Aldrich Co. LLC (U.S), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (U.S.).

About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]
Visit MarketsandMarkets Blog @http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets